Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

154.80p

Change Today:

-1.60p
52 Week High: 237.50
52 Week Low: 141.40

Currency: UK Pounds
Shares Issued: 239.42m
Volume: 132,114

Market Cap: £370.62m
Beta: 0.93

Trade now with Barclays Stockbrokers

Update - PureTech Health is a top faller in its sector - can you take advantage with spread betting? Find out more

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

1 Day Chart (24-12-2024)

6 Month Chart

More PureTech Health charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-4390.4%	-5482.0%
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	139.8	148.2
Pr/Book	1.0

	Latest	F'cast
Revenue	-78.7%	-40.2%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

PRTC Fundamentals

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	9.81	478.47	149.00¢	2.7	n/a	n/a	n/a	0.0%
31-Dec-20	11.77	18.97	2.00¢	250.9	n/a	-99%	n/a	0.0%
31-Dec-21	17.39	(58.95)	(21.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	15.62	(92.78)	(18.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	3.33	(36.10)	(24.00)¢	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

PRTC Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-24	2.50	(137.05)	(33.41)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-25	6.50	(144.30)	(43.76)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-26	14.00	(147.40)	(49.33)p	n/a	n/a	n/a	n/a	0.0%

PureTech Health forecasts

PRTC Company Announcements

PRTC's Ph2b in IPF Successful; New SOC Potential	16-Dec-2024	07:00	RNS
Holding(s) in Company	11-Dec-2024	17:30	RNS
Holding(s) in Company	27-Nov-2024	17:31	RNS

More PureTech Health prtc company announcements

PRTC ShareCast News

London close: Stocks weaker ahead of key central...	16-Dec-2024	ShareCast
PureTech hails "exciting" results from lung dise...	16-Dec-2024	ShareCast
London close: Stocks give up gains to finish in ...	21-Oct-2024	ShareCast

More PureTech Health ShareCast news

Latest PRTC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

PRTC Market Data

Currency	UK Pounds
Share Price	154.80p
Change Today	-1.60p
% Change	-1.02 %
52 Week High	237.50
52 Week Low	141.40
Volume	132,114
Shares Issued	239.42m
Market Cap	£370.62m
Beta	0.93